Table 1 Demographic, epidemiological, and clinical data of patients with Staphylococcus aureus bacteremia
From: Decreased quality of care for Staphylococcus aureus bacteremia during the COVID-19 pandemic
2019 (n = 33) | 2020 (n = 35) | p value | |
|---|---|---|---|
Age (years)* | 66 (70; 32–86) | 67 (70; 35–97) | 0.753 |
Men, n (%) | 21 (64) | 24 (69) | 0.799 |
DH (days)* | 23 (22; 2–180) | 23 (20; 2–180) | 0.394 |
MSSA/MRSA (%) | 88/12 | 86/14 | 1 |
CCI (points)* | 6.4 (6; 0–16) | 5.3 (6; 0–12) | 0.203 |
In-hospital mortality, n (%) | 2/33 (6) | 8/35 (23) | 0.085 |
MSSA, n (%)** | 0/2 (0) | 6/8 (75) | n.d |
MRSA, n (%)** | 2/2 (100) | 2/8 (25) | n.d |
Source of infection | |||
Catheter-related, n (%) | 11 (33) | 10 (29) | n.d |
Skin and soft tissue, n (%) | 8 (24) | 6 (17) | n.d |
Lung, n (%) | 5 (15) | 7 (20) | n.d |
Bone and joint, n (%) | 5 (15) | 6 (17) | n.d |
Infectious endocarditis, n (%) | 3 (10) | 4 (11) | n.d |
Urinary tract, n (%) | 0 | 1 (3) | n.d |
Unidentified, n (%) | 1 (3) | 1 (3) | n.d |